Abstract
This chapter delves into the potential of photobiomodulation (PBM) therapy for stroke, providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 1 introduces stroke, a leading cause of death and disability worldwide. The chapter discusses acute and chronic stroke (1.1), stroke-induced aphasia (1.2), and various animal models of stroke (1.3) that are crucial for understanding the disorder’s underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 2 focuses on PBM therapy for stroke, with subsections discussing its application in animal models (2.1) and human studies (2.3). This section provides a comprehensive overview of the current state of research, highlighting the potential benefits of PBM therapy in promoting neuroprotection, reducing brain damage, and enhancing functional recovery.
| Original language | English |
|---|---|
| Title of host publication | Synthesis Lectures on Biomedical Engineering |
| Publisher | Springer Nature |
| Pages | 221-258 |
| Number of pages | 38 |
| DOIs | |
| Publication status | Published - 2023 |
Publication series
| Name | Synthesis Lectures on Biomedical Engineering |
|---|---|
| Volume | Part F1286 |
| ISSN (Print) | 1930-0328 |
| ISSN (Electronic) | 1930-0336 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biochemistry
- Biomedical Engineering
Fingerprint
Dive into the research topics of 'Photobiomodulation Therapy for Stroke'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver